TY - JOUR
T1 - Diagnostic delay in focal epilepsy
T2 - Association with brain pathology and age
AU - Yang, Mengjiazhi
AU - Tan, K. Meng
AU - Carney, Patrick
AU - Kwan, Patrick
AU - O'Brien, Terence J.
AU - Berkovic, Samuel F.
AU - Perucca, Piero
AU - McIntosh, Anne M.
N1 - Funding Information:
This research was supported in part by the Royal Melbourne Hospital Home Lottery Research Fund . Grant ID PG-016-2015 .
Funding Information:
The authors thank Dr Mark R. Newton, Neurologist (First Seizure Clinic, Austin Health) for his contribution to this study including review of the Austin Health clinical data and epilepsy-related variables, and Dr Tahir M. Hakami (The Faculty of Medicine, Jazan University, Saudi Arabia) for his contribution including review and assessment of the RMH cohort epilepsy-related information. We also thank Dr David Marco, Ms Sibel Saya, Ms Madeleine Regan, Mr James Milesi, Ms Megan Cotter and Mr Rafael Smith for assistance with data collection for the study, and Ms Lisa Johnson and Ms Sue Belbin for assistance relating to the First Seizure Clinics. This research was supported in part by the Royal Melbourne Hospital Home Lottery Research Fund. Grant ID PG-016-2015.
Funding Information:
TOB was funded from NHMRC Program APP1091593 and Investigator APP1176426 grants. His-institution also has received consultancy and research funding from UCB Pharma, Eisai, ES Therapeutics, Zynerba, Praxis Pharmaceuticals and BioGen.
Funding Information:
PK was supported by a Medical Research Future Fund Practitioner Fellowship (MRF1136427). His-institution has received research grants from Biscayne Pharmaceuticals, Eisai, GW Pharmaceuticals, LivaNova, Novartis, UCB Pharma, and Zynerba outside the submitted work; he has received speaker fees from Eisai, LivaNova, and UCB Pharma outside the submitted work.
Funding Information:
PP is supported by the Australian National Health and Medical Research Council (NHMRC) (APP1163708), the Epilepsy Foundation (Australia), The University of Melbourne, Monash University, and the Weary Dunlop Medical Research Foundation. He has received speaker honoraria or consultancy fees to his institution from Chiesi, Eisai, LivaNova, Novartis, Sun Pharma, Supernus, and UCB Pharma, outside the submitted work. He is an Associate Editor for Epilepsia Open.
Publisher Copyright:
© 2022 British Epilepsy Association
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Purpose: Between 16–77% of patients with newly diagnosed epilepsy report seizures before diagnosis but little is known about the risk factors for diagnostic delay. Here, we examined the association between prior seizures and neuroimaging findings in newly diagnosed focal epilepsy. Methods: Adults diagnosed with focal epilepsy at First Seizure Clinics (FSC) at the Royal Melbourne Hospital or Austin Health, Melbourne, Australia, between 2000 and 2010 were included. Medical records were audited for seizure history accrued from the detailed FSC interview. Potentially epileptogenic brain abnormality type, location and extent was determined from neuroimaging. Statistical analysis comprised multivariate logistic regression. Results: Of 735 patients, 44% reported seizure/s before the index seizure. Among the 260 individuals with a potentially epileptogenic brain imaging abnormality, 34% reported prior seizures. Of 475 individuals with no abnormality, 50% reported prior seizures (p < 0.001). Patients with post-stroke changes had lower odds of prior seizures (n = 24/95, OR 0.5, p = 0.005) compared to patients without abnormalities, as did patients with high-grade tumors (n = 1/10, OR 0.1, p = 0.04). Abnormality location or extent was not associated with seizures. Prior seizures were inversely associated with age, patients aged >50 years had lower odds compared to those 18–30 years (OR 0.5, p = 0.01). Conclusions: A history of prior seizures is less common in patients with newly diagnosed focal epilepsy associated with antecedent stroke or high-grade tumor than in those without a lesion, and is also less common in older individuals. These findings may be related to age, biological mechanisms or aspects of diagnosis and assessment of these events.
AB - Purpose: Between 16–77% of patients with newly diagnosed epilepsy report seizures before diagnosis but little is known about the risk factors for diagnostic delay. Here, we examined the association between prior seizures and neuroimaging findings in newly diagnosed focal epilepsy. Methods: Adults diagnosed with focal epilepsy at First Seizure Clinics (FSC) at the Royal Melbourne Hospital or Austin Health, Melbourne, Australia, between 2000 and 2010 were included. Medical records were audited for seizure history accrued from the detailed FSC interview. Potentially epileptogenic brain abnormality type, location and extent was determined from neuroimaging. Statistical analysis comprised multivariate logistic regression. Results: Of 735 patients, 44% reported seizure/s before the index seizure. Among the 260 individuals with a potentially epileptogenic brain imaging abnormality, 34% reported prior seizures. Of 475 individuals with no abnormality, 50% reported prior seizures (p < 0.001). Patients with post-stroke changes had lower odds of prior seizures (n = 24/95, OR 0.5, p = 0.005) compared to patients without abnormalities, as did patients with high-grade tumors (n = 1/10, OR 0.1, p = 0.04). Abnormality location or extent was not associated with seizures. Prior seizures were inversely associated with age, patients aged >50 years had lower odds compared to those 18–30 years (OR 0.5, p = 0.01). Conclusions: A history of prior seizures is less common in patients with newly diagnosed focal epilepsy associated with antecedent stroke or high-grade tumor than in those without a lesion, and is also less common in older individuals. These findings may be related to age, biological mechanisms or aspects of diagnosis and assessment of these events.
KW - Diagnostic delay
KW - Stroke
KW - Traumatic brain injury
KW - Tumor
UR - https://www.scopus.com/pages/publications/85125481580
U2 - 10.1016/j.seizure.2022.02.004
DO - 10.1016/j.seizure.2022.02.004
M3 - Article
C2 - 35202928
AN - SCOPUS:85125481580
SN - 1059-1311
VL - 96
SP - 121
EP - 127
JO - Seizure
JF - Seizure
ER -